Integrin alpha6beta4 regulation of cancer epigenetics
Integrin alpha6beta4 regulation of cancer epigenetics
批准号:
10321610
负责人:
KATHLEEN L. O'CONNOR
金额:
$45.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-01 至 2023-12-31
关键词:
ActinsApoptosisBase Excision RepairsBasement membraneBioinformaticsBiometryBreastCarcinomaCell NucleusCellsChromatinClinicalComplexCytokeratinCytoskeletonCytosolDNADNA MethylationDNA RepairDNA Sequence AlterationDataEnhancersEnvironmentEpigenetic ProcessEventFosteringFundingGADD45A geneGene Expression RegulationGenesGenomeHeterogeneityHistonesIntegrin BindingIntegrin alpha6beta4Integrin beta4IntegrinsIntermediate FilamentsInvestigationKeratinLaboratoriesLamininLinkLiteratureMalignant NeoplasmsMediatingMethodologyMethylationModelingModificationMolecularMutationNeoplasm MetastasisNuclearNuclear TranslocationOncogenicPathway interactionsPhenotypePost-Translational Protein ProcessingProcessPropertyRegulationResearchResistanceRoleSignal TransductionSiteSolidSpecificityTestingTherapeuticTherapeutic InterventionTumor BiologyTumor Cell InvasionUntranslated RNAVimentinWorkbasebreast pathologycell motilitydemethylationemerinepigenomefallsgenome-widegenomic locusinnovationinsightleukemia/lymphomamechanotransductionmigrationnext generation sequencingnovelplectinpreventpromoterrecruitrepair enzymesensortranscriptometranscriptomicstriple-negative invasive breast carcinomatumortumor microenvironment
中文摘要
DNA去甲基化机制如何能够针对特定的基因组位点仍然知之甚少。
对肿瘤生物学有重要意义。越来越多的证据表明,微环境
影响表观遗传学;然而,指导这些事件的机制尚未阐明。我们有
证明了整合素α6β4显著改变了转录组的侵袭性表型。这个
整合素在一定程度上通过调节dna来改变表观基因组,从而调节这一过程。
精选CpG富集区和基因座去甲基化。因此,我们希望了解整合素α6β4是如何
调控癌症表观基因组是定位和机械转导表观遗传学的关键
受监管的。关于整合素α6β4如何调节dna去甲基化的研究(由NCI R21资助)导致
我们的发现整合素α6β4利用并刺激碱基切除修复途径介导
这些表观遗传事件,但不是在细胞中,其中整合素α6β4和细胞核之间的联系是
妥协了。我们还鉴定了整合素β4亚单位的特定突变,这种突变可以阻止整合素
与中间丝结合并锚定在细胞核下,从而表明整合素-
介导了核功能的改变。根据我们的初步数据和辅助文献,我们
假设整合素α6β4协调信号和机械转导到驱动误码率的细胞核
并导致选定基因座的DNA去甲基化,这反过来又增强了肿瘤的侵袭和转移。我们会
通过完成以下三个目标来测试我们的中心假设:1)确定整合素α6β4如何
细胞骨架联系影响侵袭、转移和表观遗传学,2)阐明整合素α6β4如何调节
BER介导的脱甲基化,以及3)定义整合素α6β4介导的表观基因组的变化
发信号。我们期望通过阐明整合素α6β4所使用的基因和途径来调节
对于特定基因的去甲基化,我们将提供对基因组中特定位置如何的关键洞察
去甲基化以培育侵袭性和转移性转录组。
英文摘要
How DNA demethylation machinery can be targeted to specific genomic loci is still poorly understood, yet
has important implications for tumor biology. Mounting evidence suggests that the microenvironment
influences epigenetics; however, the mechanisms guiding these events have not been elucidated. We have
demonstrated that integrin α6β4 dramatically alters the transcriptome toward an invasive phenotype. The
integrin regulates this process, in part, by substantially changing the epigenome through the regulation of DNA
demethylation of select CpG rich regions and loci. Thus, we expect that understanding how integrin α6β4
regulates the cancer epigenome holds the key to how site-specific and mechanotransduced epigenetics are
regulated. Investigations into how integrin α6β4 regulates DNA demethylation (funded by an NCI R21) led to
our discovery that integrin α6β4 utilizes and stimulates the base excision repair (BER) pathway to mediate
these epigenetic events, but not in cells in which the link between integrin α6β4 and the nucleus is
compromised. We have also identified specific mutations in integrin β4 subunit that preventing the integrin from
binding to intermediate filaments and anchoring under the nucleus, thus indicating a pathway for integrin-
mediated alterations in nuclear function. Based on our preliminary data and supporting literature, we
hypothesize that integrin α6β4 coordinates signal and mechano-transduction to the nucleus that drives BER
and results in DNA demethylation of select loci, which in turn enhances tumor invasion and metastasis. We will
test our central hypothesis through completion of the following three aims: 1) Determine how integrin α6β4
cytoskeletal linkages impacts invasion, metastasis and epigenetics, 2) Elucidate how integrin α6β4 regulates
BER-mediated DNA demethylation, and 3) Define changes in the epigenome mediated by integrin α6β4
signaling. We expect that by elucidating the genes and pathways used by integrin α6β4 to modulate the
demethylation of select genes, we will provide critical insight into how specific sites within the genome are
demethylated to foster an invasive and metastatic transcriptome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrin alpha6beta4 regulation of cancer epigenetics
-
批准号:10551214
-
项目类别:
-
资助金额:$45.67万
-
财政年份:2019
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Career Enhancement
-
批准号:10204883
-
项目类别:
-
资助金额:$9.21万
-
财政年份:2013
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Cancer Research Training and Education Coordination
-
批准号:10712116
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2013
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Career Enhancement
-
批准号:10470102
-
项目类别:
-
资助金额:$9.21万
-
财政年份:2013
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Integrin Contributions to Pancreatic Cancer
-
批准号:7609159
-
项目类别:
-
资助金额:$3.43万
-
财政年份:2008
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Integrin Contributions to Pancreatic Cancer
-
批准号:7845314
-
项目类别:
-
资助金额:$13.55万
-
财政年份:2008
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Integrin Contributions to Pancreatic Cancer
-
批准号:7470886
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2008
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:7034331
-
项目类别:
-
资助金额:$26.8万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:8295796
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:8526404
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:8831603
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:7540460
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:7336346
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:7197288
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Novel Mechanisms of Carcinoma Cell Migration
-
批准号:8634032
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2006
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Spatial control of cAMP/PKA by integrin receptors
-
批准号:6806105
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2004
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Spatial control of cAMP/PKA by integrin receptors
-
批准号:6950021
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2004
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Pancreatic Integrin Contribution to Perineural Invasion
-
批准号:6671964
-
项目类别:
-
资助金额:$11.33万
-
财政年份:2003
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
Pancreatic Intergin Contribution to Peerineural Invasion
-
批准号:6788151
-
项目类别:
-
资助金额:$11.33万
-
财政年份:2003
-
负责人:KATHLEEN L. O'CONNOR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: